[1] BURNETT E, CORLETT J. Understanding risk perceptions and responses of the public and health care professionals toward Clostridium difficile: a qualitative interpretive description study [J].Am J Infect Control, 2017, 45(2):133-138.
[2] 廖亚龙,侯铁英,邵裕燊,等.艰难梭菌感染临床特征与危险因素分析[J].中华医院感染学杂志,2016,26(21):4837-4840.
[3] MAGILL S S, EDWARDS J R, BAMBERG W, et al.Multistate point-prevalence survey of health care-associated infections[J].N Engl J Med, 2014,370(13):1198-1208.
[4] NAPOLITANO L M, EDMISTON C E. Clostridium difficile disease: diagnosis, pathogenesis, and treatment update [J].Surgery, 2017, 162(2):325-348.
[5] TANG C, CUI L, XU Y, et al.The incidence and drug resistance of Clostridium difficile infection in mainland China: a systematic review and meta-analysis [J].Sci Rep, 2016, 6: 37865.
[6] RODRIQUEZ C, VAN BROECK J, TAMINIAU B, et al.Clostridium difficile infection: early history, diagnosis and molecular strain typing methods [J].Microb Pathog, 2016, 97: 59-78.
[7] NICHOLAS A, KIM Y K, LEE W K, et al.Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals [J].PLoS One, 2017, 12(3):e174716.
[8] SHEA K M, HOBBS A L V, JASO T C, et al.Effect of a health care-system respiratory fluoroquinolone restriction program to alter utilization and impact rates of Clostridium difficile infection[J].Antimicrob Agents Chemother, 2017,61(6):e00125-17.
[9] 章黎华,李贞,江岑,等. 3种检测艰难梭菌方法的临床应用评估[J].微生物与感染, 2016,11(1):24-27.
[10] CHEN S Y, GU H W, SUN C L, et al.Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections[J].Infection, 2017, 45(3):255-262.
[11] 杨靖,赵建宏.艰难梭菌感染实验室诊断的研究进展[J].临床荟萃, 2018,33(5):373-376.
[12] HUSSACK G, TANHA J. An update on antibody-based immunotherapies for Clostridium difficile infection [J].Clin Exp Gastroenterol, 2016, 9(1):209-224.
[13] ADLERBERTH I, HUANG H, LINDBERG E,et al.Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants[J].J Clin Microbiol,2013,52 (1):173-179.
[14] 温海楠,田甜甜,赵建宏,等.粪便中艰难梭菌三种培养方法的比较[J].中国微生态学杂志,2017,29(3):351- 353, 356.
[15] MARTÍNEZ-MELÉNDEZ A, CAMACHO-ORTIZ A, MORFIN-OTERO R, et al.Current knowledge on the laboratory diagnosis of Clostridium difficile infection[J].World J Gastroenterol,2017,23(9):1552-1567.
[16] SHETTY N, WREN M, COEN P G. The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis [J].J Hosp Infect, 2011, 77(1):1-6.
[17] KOCIOLEK L K. Strategies for optimizing the diagnostic predictive value of Clostridium difficile molecular diagnostics [J].J Clin Microbiol,2017, 55(5):1244-1248.
[18] 王丽志,陈丽丹,肖斌,等.3种艰难梭菌感染检测方法的比较[J].南方医科大学学报,2017,37(12):1648-1653.
[19] 王瑞莲,林丽娟,付亮,等.艰难梭菌在腹泻患者中感染情况的调查[J].实用医学杂志,2015,31(3):144-146.
[20] SHIN B M, LEE E J, KUAK E Y, et al.Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcd A(-)tcd B(+)C. difficile prevalent area [J].Anaerobe, 2009, 15 (6):266-269.
[21] ERB S, FREI R, STRANDÉN A M, et al.Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients[J].Clin Microbiol Infect,2015,21(11):998e9-998e15.
[22] SONG L A, ZHAO M W, DUFFY D C, et al.Development and validation of digital enzyme-linked immunosorbent assays for ultrasensitive detection and quantification of Clostridium difficile toxins in stool[J].J Clin Microbiol, 2015, 53(10):3204-3212.
[23] MURAD Y M, PEREZ J, YBAZETA G, et al.False negative results in Clostridium difficile testing [J].BMC Infect Dis, 2016, 16(1):430.
[24] 杨旭,彭子元,吴永华.艰难梭菌实验室检测方法的进展[J].中华医院感染学杂志,2016,26(23):5511-5513.
[25] CAIRNS M D, PRESTON M D, HALL C L, et al.Comparative genome analysis and global phylogeny of the toxin variant Clostridium difficile PCR ribotype 017 reveals the evolution of two independent sublineages[J].J Clin Microbiol,2017,55(3):865- 887.
[26] YANG J J, NAM Y S, KIM M J, et al.Evaluation of a chromogenic culture medium for the detection of Clostridium difficile[J].Yonsei Med J, 2014, 55(4):994-998.
[27] NGUYEN H H, MILAT F, VINCENT A. Premature ovarian insufficiency in general practice: meeting the needs of women [J].Aust Fam Physician, 2017, 46(6):360-366.
[28] WEBBER L, DAVIES M, ANDERSON R, et al.ESHRE Guideline: management of women with premature ovarian insufficiency [J].Hum Reprod, 2016, 31 (5):926-937.
[29] SMITS W K, LYRAS D, LACY D B, et al.Clostridium difficile infection[J].Nat Rev Dis Primers,2016, 2:16020.
[30] PALLIS A, JAZAYERI J, WARD P, et al.Rapid detection of Clostridium difficile toxins from stool samples using realtime multiplex PCR[J].J Med Microbiol,2013,62(9):1350-1356.
[31] 杨天翔,戴伟,贾晓炯,等.不同产毒类型艰难梭菌耐药性特征分析[J].中华医院感染学杂志,2018,28(9):1334-1337, 1341.
[32] PAITAN Y, MILLER-ROLL T, ADLER A. Comparative performance study of six commercial molecular assays for rapid detection of toxigenic Clostridium difficile [J].Clin Microbiol Infect, 2017, 23(8):567-572.
[33] BOMOON S, SUNMEE Y, WONCHANG S. Evaluation of Xpert C.difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile assays for direct detection of toxigenic Clostridium difficile in stool specimens [J].Ann Lab Med, 2016, 36(2):131-137.
[34] 黄旭,刘成成,徐婷,等. Xpert 艰难梭菌检测系统的临床应用评价[J].临床检验杂志,2017,35(1):36-38.
[35] BABADY N E, STILES J, RUGGIERO P, et al.Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital[J].J Clin Microbiol, 2010,48(12):4519-4524.
[36] NEUENDORF M,GUADARRAMA-GONZALEZ R, LAMIK B, et al.A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection [J].BMC Microbiol, 2016, 16(1):1-6.
[37] PÉREZ-TOPETE S E, MIRANDA-AQUINO T, HERNÁNDEZ-PORTALES J A. Positive predictive value of the immunoassay for Clostridium difficile toxin A and B detection at a private hospital [J].Rev Gastroenterol Mex, 2016, 81(4):190-194.
[38] ELEWA A, SAYED-ZAKI M E. Evaluation of nested polymerase chain reaction and immunoassay for rapid diagnosis of Clostridium difficile in children with community acquired diarrhea [J].Clin Lab, 2017, 63(2):321-326.
[39] ZHOU P C, ZHOU N, SHAO L, et al.Diagnosis of Clostridium difficile infection using an UPLC-MS based metabolomics method[J].Metabolomics, 2018, 14:102. |
